Phenomex Inc.
(NASDAQ GS: CELL)
Rigrodsky Law, P.A. is investigating PhenomeX Inc. regarding possible breaches of fiduciary duties and other violations of law related to PhenomeX’s agreement to be acquired by Bruker Corporation. Under the terms of the agreement, PhenomeX shareholders will receive $1.00 per share in cash.